Simple blood test could open lifesaving cancer drug to more patients
Diagnosis
Ongoing
This study is testing whether a blood test can more accurately identify patients with advanced bladder cancer who are eligible for a targeted drug called erdafitinib. Currently, doctors use a tissue sample from a past biopsy, which may not reflect the current state of the cancer.…
Sponsor: Bernie Eigl • Aim: Diagnosis
Last updated Mar 25, 2026 14:07 UTC